Literature DB >> 31028579

Experimental Substantiation of Application of Semax as a Modulator of Immune Reaction on the Model of "Social" Stress.

M A Samotrueva1, A L Yasenyavskaya2, V Kh Murtalieva1, O A Bashkina1, N F Myasoedov3, L A Andreeva3, A V Karaulov4.   

Abstract

We studied immunocorrecting effects of Semax (Met-Glu-His-Phe-Pro-Gly-Pro) on the model of "social" stress caused by sensory contact and intermale confrontation. Functional activity of the immune system of laboratory animals was evaluated in standard immunopharmacological tests: delayed-type hypersensitivity reaction, direct agglutination test, latex test for studying phagocytic activity of peripheral blood neutrophils, changes in differential leukocyte count, and weight of immunocompetent organs. It was found that changes in the immune response caused by "social" stress are multidirectional, which confirms the theory of stress-induced "immune imbalance". Semax acted as effective immune corrector restoring cellular and humoral immunogenesis reactions and phagocytic activity of neutrophils. This attested to the presence of immunomodulating properties in Semax and necessitates further studies in this field.

Entities:  

Keywords:  Semax; immune system; sensory contact; social stress

Mesh:

Substances:

Year:  2019        PMID: 31028579     DOI: 10.1007/s10517-019-04434-y

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

1.  Morphofunctional State of the Large Intestine in Rats under Conditions of Restraint Stress and Administration of Peptide ACTH(4-7)-PGP (Semax).

Authors:  M V Svishcheva; Ye S Mishina; O A Medvedeva; I I Bobyntsev; A Y Mukhina; P V Kalutskii; L A Andreeva; N F Myasoedov
Journal:  Bull Exp Biol Med       Date:  2021-01-18       Impact factor: 0.804

2.  The effects of compression load to the trunk on lipid metabolism in an inactive phase.

Authors:  Kousuke Shimada; Masakatsu Nohara; Fumika Shinozaki; Midori Tatsuda; Takayuki Watanabe; Asuka Kamei; Keiko Abe
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.